FDA Approved: ALMOTRIPTAN MALATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application to allow the sale of almotriptan malate (almotriptan) as a generic product by Mylan for acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Almotriptan malate (almotriptan)

Snippet

SUPPL AP for ALMOTRIPTAN MALATE (ALMOTRIPTAN)